What is the LiBBY Study?
The Life’s-end Benefits of cannaBidiol and tetrahYdrocannabinol (LiBBY) Study is the first of its kind to examine possible benefits of Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) as a safe treatment option for hospice-eligible people with agitation and any type of dementia. The LiBBY Study has sites across the United States.
Who is Eligible?
- Dementia diagnosis
- Adults age 40 or older
- Experiencing agitation
- In hospice or hospice eligible
- Have a study/care partner
Visit LibbyStudy.org or call 1-800-LiBBY-11.